Evidence map›Paper›PMID 32900354›Full record

ReviewAnti-cancer agents in medicinal chemistry2021

Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.

Sachin Sharma, Arshdeep Singh, Sahil Sharma, Ram Sharma, Jagjeet Singh, Nihar Kinarivala, Kunal Nepali, Jing P Liou

Abstract readReview
In one paragraph

Review in Anti-cancer agents in medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sachin SharmaSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Arshdeep SinghSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Sahil SharmaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Ram SharmaSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Jagjeet SinghSchool of Pharmacy, University of Queensland, Brisbane, QLD, Australia.
Nihar KinarivalaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Kunal NepaliSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Jing P LiouSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundQuinoline is considered to be a privileged heterocyclic ring owing to its presence in diverse scaffolds endowed with promising activity profiles. In particular, quinoline containing compounds have exhibited substantial antiproliferative effects through the diverse mechanism of actions, which indicates that the heteroaryl unit is flexible as well as accessible to subtle structural changes that enable its inclusion in chemically distinct anti-tumor constructs.

methodsHerein, we describe a medicinal chemistry perspective on quinolines as anticancer agents by digging into the peer-reviewed literature as well as patents published in the past few years.

resultsThis review will serve as a guiding tool for medicinal chemists and chemical biologists to gain insights about the benefits of quinoline ring installation to tune the chemical architectures for inducing potent anticancer effects.

conclusionQuinoline ring containing anticancer agents presents enough optimism and promise in the field of drug discovery to motivate the researchers towards the continued explorations on such scaffolds. It is highly likely that adequate efforts in this direction might yield some potential cancer therapeutics in the future.

Indexed as

Antineoplastic AgentsChemistry, PharmaceuticalHumansMolecular StructureNeoplasmsQuinolinesAntineoplastic AgentsQuinolinesanticancercell linecytotoxicheterocyclemedicinalQuinolinescaffold

Identifiers

PMID32900354
PMCPMC9169701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.